Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01083914 · ClinicalTrials.gov registry record

Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB

A clinical trial of Coronary Artery Disease, sponsored by Baylor Research Institute.

Completed
Registry status
102
Enrollment target
1
Study location

NCT01083914 is a study of Coronary Artery Disease that has completed, run by Baylor Research Institute. The registered enrollment target is 102 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01083914, a study of Coronary Artery Disease, has completed, sponsored by Baylor Research Institute.

COMPLETED
Registry status
102 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare blood loss and the number of transfusions received by each patient having coronary bypass surgery. The second purpose is to determine how the level inflammation in patients during and after surgery may affect a patient's response to surgery and the recovery process.

Conditions Studied

Coronary Artery Disease

Study Locations (1)

Texas

  • The Heart Hospital at Baylor Plano - Plano

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2010-03
Est. Completion 2011-09

Sponsor

Baylor Research Institute

180 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01083914

The ClinicalTrials.gov registry entry for NCT01083914 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (92% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT01083914 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01083914 about?

NCT01083914 is a clinical study titled "Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB". The purpose of this study is to compare blood loss and the number of transfusions received by each patient having coronary bypass surgery. The second purpose is to determine how the level inflammation in patients during and after surgery may affect a patient's response to surgery and the recovery pr...

What is the current status of trial NCT01083914?

This trial is currently completed. The enrollment target is 102 participants. The study started on 2010-03. Estimated completion is 2011-09.

What conditions does trial NCT01083914 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT01083914?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01083914 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.